Fil d'actualités

ANRS 2017-2018 business report

Registrations for the 6th HBV cure workshop now open

Isoniazid preventive therapy (IPT): Time to use it !  "Science has spoken"

A study from the ANRS HEPAVIH prospective cohort is the first to investigate the relationship between coffee consumption and the risk of all-cause mortality in HIV-HCV co-infected patients. Indeed, coffee is known to…

The Paris Statement: HIV Science Matters

ANRS 12286 MOBIDIP1, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is…